Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for Dyskinesia in Parkinson's Disease
NCT01789047Phase 2Terminated
- Sponsor
- Rush University Medical Center
- Start
- Mar 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in dyskinesia, sponsored by Rush University Medical Center. Started Mar 2013; status: terminated.
02
Drugs
topiramate
03
Conditions
dyskinesia
Beyond the preview
Go deeper on NCT01789047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789047.